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Background: Suspicion of acute coronary syndrome (ACS) is one of the most common
reasons for hospital admission. However, ACS is not conﬁrmed in a high proportion of
these patients during hospitalization. Very few details exist about these patients.
Aim: To evaluate the clinical characteristics and outcomes of hospitalized patients with a
suspicion for ACS that has not been conﬁrmed and compare these results with patients with
conﬁrmed ACS.
Methods and results: Data were used from the CZECH-1 and CZECH-2 registries, collected in
November 2005 and October–November 2012. Both registries contain data from all conse-
cutive patients who have been hospitalized with an initial diagnosis of ACS. ACS was not
conﬁrmed during hospitalization in 578 of 1921 patients (30.1%) in the CZECH-1 registry
and in 372 of 1221 (30.5%) in the CZECH-2 registry. In both registries, higher proportions of
females (52 vs. 36%; p < 0.001 and 46 vs. 33%; p < 0.01, respectively) were observed
between patients with unconﬁrmed ACS compared to those with conﬁrmed ACS. A history
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of myocardial infarction was known in 25% of the patients with unconﬁrmed ACS in both
registries. On admission, atrial ﬁbrillation or other non-sinus rhythm on ECG was present
in 17% of patients with unconﬁrmed ACS, bundle branch block in 18%, ST depression in
8%, and ST elevation in 3.6%. Coronary angiography was performed on 36% of these
patients in CZECH-1 and 27% of patients in CZECH-2 ( p < 0.01). In-hospital mortality of
the ACS unconﬁrmed patients was 1.2% in the CZECH-1 registry and 2.1% in the CZECH-2
registry ( p = NS). 30-day and 1-year mortality in patients with unconﬁrmed ACS in
the CZECH-2 registry were signiﬁcantly lower compared to patients with conﬁrmed
ACS (3.5 vs. 6.6%; p < 0.05 and 6.5 vs. 13%; p < 0.05, respectively). Musculoskeletal pain
and acute heart failure were the most common discharge diagnosis in patients with
unconﬁrmed ACS.
Conclusion: Hospitalized patients in whom the suspicion of ACS had not been conﬁrmed
were more often female and a high proportion had abnormal ECG on admission. In-hospital
mortality was very low, and the 1-year mortality was signiﬁcantly lower compared to
patients with conﬁrmed ACS.
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. heTIntroduction
Clinical symptoms indicating acute coronary syndrome (ACS)
are among the most common reasons for presentation to
hospitals. Because of the challenge of determining an
appropriate diagnosis and the poor clinical outcome of
mistakenly discharged patients with myocardial infarction
(MI), a high proportion of patients are admitted with possible
ACS that subsequently is not conﬁrmed [1,2].
Two large registries of patients with an initial diagnosis of
ACS admitted to regional community hospitals or cardiocen-
tres were created in 2005 and 2012 in the Czech Republic [3,4].
In both registries, ACS diagnosis was excluded during
hospitalization in 30% of patients.
The aim of this study was to evaluate the clinical
characteristics and outcomes of patients enrolled in the
CZECH-1 and CZECH-2 registries in whom ACS was not
conﬁrmed.
Methods
CZECH-1 registry data were collected from 1 to 30 November
2007 in all 21 cardiocentres (PCI centres) and 15 regional
community hospitals without catheterization availability.
CZECH-2 registry data were obtained between 1 October and
30 November 2012 from 28 regional hospitals without
catheterization availability and 4 cardiocentres with catheter-
ization laboratories. Detailed descriptions of the participating
centres have been presented previously [5]. One-year clinical
follow-ups of 1002 of 1221 (82%) patients enrolled in the
CZECH-2 registry were performed by the investigators between
October 2013 and February 2014.
The inclusion criteria for both registries were the same:
hospital admission with a diagnosis of ST segment elevation
MI (STEMI), non-ST segment elevation MI (NSTEMI), unstable
angina pectoris (UAP), acute heart failure in patients with
known coronary artery disease (CAD), chest pain with
suspected ACS, resuscitation in the prehospital phase, oranother initial diagnosis conﬁrmed as ACS during hospitali-
zation.
In-hospital mortality was evaluated in all enrolled patients.
The ﬁnal diagnosis and the conﬁrmation or exclusion of ACS
were performed according to the criteria for and deﬁnition of
ACS [6,7]. Retrospectively, the correct ﬁnal diagnosis of
patients with unconﬁrmed ACS was evaluated in some
CZECH-2 participating centres of the South Bohemia county.
Standard descriptive statistics were applied in the analysis,
including absolute and relative frequencies for categorical
variables and means with standard deviations for continuous
variables. The statistical signiﬁcance of the differences among
patient groups was computed using the maximum likelihood
chi-square test for categorical variables and analysis of
variance (ANOVA) for continuous variables. The level of
statistical signiﬁcance was set at p = 0.05. SPSS 19 for Windows
(Release 19.0.1; IBM Corp., 2010) was used for the analysis.
Results
ACS was not conﬁrmed during hospitalization in 578 of 1921
patients (30.1%) in the CZECH-1 registry and in 372 of 1221
(30.5%) in the CZECH-2 registry. There was a signiﬁcant
difference in the proportion of unconﬁrmed ACS patients
between regional community hospitals and cardiocentres
(Fig. 1).
Patient characteristics
The clinical characteristics of patients with unconﬁrmed ACS
did not differ between CZECH-1 and CZECH-2 registry except of
prevalence of dyslipidemia (39 vs. 48%, p < 0.01). Table 1 shows
comparison of clinical characteristics between the uncon-
ﬁrmed and conﬁrmed ACS patients.
Clinical examination and treatment strategy
Patients with unconﬁrmed ACS in the two registries did not
differ in terms of their initial ECGs. Thus, we present these
Fig. 1 – Proportion of unconfirmed ACS patients among the
total patients with a suspicion of ACS enrolled into the
CZECH-1 and CZECH-2 registries at regional community
hospitals and cardiocentres.
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ﬁbrillation or other non-sinus rhythm on ECG was present
in 17% of patients, bundle branch block was observed in 18%,
ST depression in 8%, and ST elevation in 3.6%. Coronary
angiography was performed in 36% of patients with uncon-
ﬁrmed ACS in the CZECH-1 and 27% of patients in the CZECH-2
registry ( p < 0.01). Of these patients, coronary angiography
without signiﬁcant coronary stenosis was present in 78 andTable 1 – Comparison of characteristics of patients with
unconfirmed and confirmed ACS in the CZECH-1 and
CZECH-2 registries.
CZECH-1 registry p
ACS not
conﬁrmed
Conﬁrmed
ACS
Female 52% 36% <0.001
Age, years (SD) 68 (12) 67 (12) <0.050
Diabetes 27% 32% <0.050
Hypertension 69% 70% 0.827
Active smoking 18% 28% <0.001
Dyslipidemia 39% 40% 0.508
History of MI 24% 27% 0.054
History of PCI 16% 15% 0.489
History of CABG 8% 7% 0.442
CZECH-2 registry p
ACS not
conﬁrmed
Conﬁrmed
ACS
Female 46% 33% <0.001
Age, years (SD) 67 (13) 68 (12) <0.010
Diabetes 32% 36% 0.190
Hypertension 73% 70% 0.269
Active smoking 17% 31% <0.001
Dyslipidemia 48% 47% 0.803
History of MI 25% 25% 0.906
History of PCI 21% 20% 0.725
History of CABG 10% 10% 0.836
ACS, acute coronary syndrome; MI, myocardial infarction; PCI,
percutaneous coronary intervention; CABG, coronary artery bypass
graft.71% of patients ( p = 0.154), respectively. Cardiac markers were
entered to database only in the CZECH-2 registry. Troponin
was elevated in 21% of patients with unconﬁrmed ACS and
MB-fraction of creatininkinase in 15% of patients. The
medications prescribed at discharge are shown in Table 2.
Clinical outcome
In-hospital mortality of the unconﬁrmed ACS patients was
1.2% in the CZECH-1 registry and 2.1% in the CZECH-2 registry
( p = NS). Comparison of the in-hospital, 30-day and 1-year
clinical outcome between patient with and without conﬁrma-
tion of the ACS in the CZECH-2 registry is shown in Table 3. A
cardiovascular cause of death in patients with unconﬁrmed
ACS was determined in 55% of patients. Two patients (0.8%)
with previously excluded ACS suffered MI during the 1-year
follow-up in the CZECH-2 registry.
True discharge diagnosis in patients with unconﬁrmed ACS
Exact ﬁnal diagnosis was retrospectively evaluated in 68 from
372 (18%) patients with unconﬁrmed ACS in the CZECH-2
registry. Out of these patients, 22 (32%) patients had discharge
diagnosis of musculoskeletal pain, 7 (10%) patients were
discharged with ﬁnal diagnosis of heart failure, 6 (9%) patients
had decompensation of hypertension, 5 (7%) patients atrial
ﬁbrillation or other supraventricular tachycardia, 3 (4%)
patients suffered of perimyocarditis and in 4 (6%) patients
clinical symptoms of ACS was caused by gastrointestinal
disorders. In 2 (3%) patients pulmonary embolism and in 1
(1.5%) patient acute aortic dissection was diagnosed. The rest
of 18 (26%) patients had other non cardiovascular discharge
diagnosis.
Discussion
In this study, we analyzed the characteristics, treatment
strategy, and outcome of patients admitted to the hospital for
a suspicion of ACS, which was not subsequently conﬁrmed
during the hospital stay. We have focused on this speciﬁc
patient subgroup because high proportions of these patients
were observed in the CZECH-1 and CZECH-2 registries, which
evaluated all consecutive patients admitted with an initial
diagnosis of ACS.Table 2 – Medication at discharge in patients with
unconfirmed ACS.
CZECH-1
registry
CZECH-2
registry
p
ASA 52% 53% 0.789
Clopidogrel 4% 10% <0.010
Warfarin Not done 16% Not applicable
ACEI/ARB 52% 67% <0.001
Beta-blocker 52% 55% 0.542
Statin 43% 55% <0.010
ASA, acetylsalicylic acid; ACEI, angiotensin-converting enzyme
inhibitors; ARB, angiotensin II receptors blockers.
Table 3 – In-hospital, 30-day and 1-year outcome of
patients with unconfirmed and confirmed ACS in the
CZECH-2 registry.
Unconﬁrmed
ACS
Conﬁrmed
ACS
p
In-hospital mortality 2.1% 5.2% <0.050
30-day mortality 3.5% 6.6% <0.050
1-year mortality 6.5% 13% <0.001
MI (at 1 year) 0.8% 3.1% <0.050
Stroke (at 1 year) 1.3% 1.5% 0.796
Major bleeding (at 1 year) 1.0% 2.6% 0.086
Heart failure
rehospitalization
(30 day–1 year)
5.9% 7.2% 0.298
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data from unselected patients admitted with a suspicion of
ACS. Furthermore, unequivocal information about uncon-
ﬁrmed ACS patients has been presented. The internet
tracking registry of ACS (i*trACS), performed 15 years ago,
included very low-risk patients, of whom 80% of admitted
patients had diagnoses other than MI or unstable angina [2].
On the other hand, in the Global Registry of Acute Coronary
Events (GRACE) and Canadian Registry of Acute Coronary
Events (CANRACE) registries, only 14% of high-risk patients
did not have a ﬁnal diagnosis of ACS [7,8]. The Australian
SNAPSHOT ACS registry was performed in the same period as
the CZECH-2 registry using similar methodology. A ﬁnal
diagnosis of unlikely ischaemic chest pain was present in
27% of patients and diagnoses other than ACS in 19% of
patients [9].
In our study, unconﬁrmed ACS patients usually had one or
more risk factors for atherosclerosis, with a high percentage
having a known history of coronary artery disease or
abnormal ECG on admission. The only two characteristics
differing from those of patients with conﬁrmed ACS in both
registries were the higher proportions of females and non-
smokers. Thus, men and smokers can be regarded as high-risk
patients who physicians should not take the risk of dischar-
ging after the ﬁrst clinical examination. The explanation, why
females have more frequently excluded ACS cannot be easily
obtained from our data. It has been previously described, that
females evaluated for chest pain have more frequently non-
cardiac cause or other non-atherosclerotic cause, such as
vasospasm [10].
Even if ACS is excluded during examination, patients could
have other life-threatening diseases. This is supported by the
fact that 20% of patients had elevated levels of serum troponin.
Troponin elevation is common in many non-coronary dis-
eases, such as acute perimyocarditis, pulmonary embolism,
aortic dissection, heart failure, Tako-tsubo cardiomyopathy,
tachycardias, and it is a marker of increased cardiac and all-
cause morbidity and mortality [11–13]. We have observed
differences in the proportion of unconﬁrmed ACS patients
between regional community hospitals and cardiocentres.
Based on our data, we have one possible explanation for this
observation. Lower proportion of patient admitted to regional
hospitals had coronary angiography compared to cardiocen-
tres [5]. Thus, the information of coronary arteries status was
missing. This is an important criterium for the deﬁnition ofunstable angina in patient with chest pain without troponin
elevation.
The main limitation of our study was that an exact ﬁnal
diagnosis was determined retrospectively only in a small
portion of patients with unconﬁrmed ACS. Next to this
incomplete evaluation, we can assume from our other
analysis that acute heart failure was the principal diagnosis
in approximately 15% of all unconﬁrmed ACS patients. In the
CZECH-2 registry, ACS was not conﬁrmed in 57 of 111 (51.4%)
patients admitted for acute heart failure without chest
pain [4].
Conclusion
In daily clinical practice, ACS is not conﬁrmed in a high
proportion of patients admitted to the hospital with suspected
ACS. These patients mostly represent a high-risk population,
often with a known history of ACS. Although the in-hospital
mortality of this subgroup of patients was low, the 1-year
mortality was not negligible.
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